Literature DB >> 6245127

Interactions among rheumatoid synovial cells and monocyte-macrophages: production of collagenase-stimulating factor by human monocytes exposed to concanavalin A or immunoglobulin Fc fragments.

J M Dayer, J H Passwell, E E Schneeberger, S M Krane.   

Abstract

Adherent synovial cells (ASC) were obtained from minced synovium from patients with rheumatoid arthritis by dissociating the lining cells from the extracellular matrix and dispersing them with proteases. These cells produce high levels of latent collagenase in primary culture. With passage of ASC, collagenase levels decrease but can be stimulated by a soluble factor (MCF) released in vitro from cultured human blood monocyte-macrophages. Monocyte cultures exposed to aggregated immunoglobulin, Fc fragments of immunoglobulin or concanavalin A (Con A) increase production of MCF several-fold more than the control cultures. MCF production by monocytes exposed to Fab fragments does not differ from controls. Although aggregated immunoglobulin, Fc fragments, and Con A stimulate PGE2 synthesis and secretion by human monocytes, the effects on MCF production are not mediated by PGE2 since concentrations of indomethacin that completely block PGE2 production do not inhibit MCF production. These findings of increased production of MCF by monocytes in response to substances that probably exert their effects via surface receptors could be relevant in interpreting the in vivo role of immune complexes in diseases associated with connective tissue destruction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245127

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Synovial lining cells.

Authors:  P A Revell
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Interactions of cultured rat synovial and ocular ciliary body cells with two strains of Mycoplasma arthritidis.

Authors:  C E Thirkill; A M Roth; R J Munn; P Lee; N K Tyler
Journal:  In Vitro Cell Dev Biol       Date:  1990-02

3.  Differential expression of Ia antigens by rheumatoid synovial lining cells.

Authors:  G R Burmester; B Jahn; P Rohwer; J Zacher; R J Winchester; J R Kalden
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

4.  Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells.

Authors:  J Chin; E Rupp; P M Cameron; K L MacNaul; P A Lotke; M J Tocci; J A Schmidt; E K Bayne
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  Immunohistology of rheumatoid nodules and rheumatoid synovium.

Authors:  N A Athanasou; J Quinn; C G Woods; J O Mcgee
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

6.  Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells.

Authors:  F A Nardella; J M Dayer; M Roelke; S M Krane; M Mannik
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

7.  Rheumatoid synovial cell hormone responses modulated by cell-cell interactions.

Authors:  S R Goldring; J M Dayer; S M Krane
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

8.  Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.

Authors:  H E Jasin; J T Dingle
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

9.  Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines.

Authors:  E N Unemori; M S Hibbs; E P Amento
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Collagen metabolism in fibrotic liver. Effects of concanavalin A and aggregated myeloma immunoglobin G.

Authors:  S Takahashi; M J Lee
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.